Estrogen-receptor-positive breast cancer
Clinical trials for Estrogen-receptor-positive breast cancer explained in plain language.
Never miss a new study
Get alerted when new Estrogen-receptor-positive breast cancer trials appear
Sign up with your email to follow new studies for Estrogen-receptor-positive breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Daily pill giredestrant put to the test for sticking with breast cancer treatment
Disease control Not yet recruitingResearchers are studying giredestrant, an experimental daily pill, in people with estrogen receptor-positive, HER2-negative early breast cancer. The trial enrolls about 1,500 participants, including some who switch to giredestrant after other treatments. It tracks how many people…
Matched conditions: ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a 'Baby Dose' of hormone pills prevent breast cancer?
Prevention Not yet recruitingThis study tests whether low doses of two hormone-blocking drugs, exemestane and tamoxifen, can help prevent breast cancer in postmenopausal women at high risk. About 140 women will take one of the two drugs for a year, and researchers will measure side effects and quality of lif…
Matched conditions: ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC